Navigation Links
Peptide Machines, Inc. Introduces New High-Quality, Cost-Efficient, Fully Automated Multiple Peptide Synthesizer with Preactivation
Date:8/23/2013

San Diego, CA (PRWEB) August 23, 2013

Discovery-4 is a 4-vessel peptide synthesizer designed to overcome the shortcomings and unnecessary complexity of existing synthesizers. The unique design prevents any precipitation, clogged lines, and overfills so typical of other instruments. The use of stock solutions of AA's eliminates the need for pre-fill cartridges or barcoding. The Discovery-4 has a preactivation vessel for every reaction vessel, which allows the synthesis of excellent quality peptides with a single coupling protocol.

The instrument's inherent flexibility for reagent set-up makes Discovery-4 very effective for both small and large scale synthesis from 0.05 mmol to 3 mmol. The system's precise metering pump delivery, patented solvent measuring device, and drastic washes reduction, cuts reagent and solvent consumption in half, thus reducing cost and minimizing waste. Discovery-4 utilizes 30, 60 and 100 ml glass reactors with removable filters. Each reactor can run independently with different scales and protocols.

The easy to use powerful software allows the user to effortlessly import sequences from USB, assign protocols to sequences, and sequences to reaction vessels. The calculation table, which is generated, provides the quantity of reagents required, allowing the user to very quickly go from an idea to execution.

The small footprint and fully ventilated hood make Discovery-4 suitable for any size peptide lab. With all this and more, the Discovery-4 is an ideal tool for R&D, process optimization, and peptide production.

For more information please visit http://www.peptidemachines.com/.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11051115.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
2. Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics
3. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
4. New Book Chapter from CEM on Microwave Peptide Synthesis
5. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
6. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
7. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
8. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
9. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
10. Small peptide ameliorates autoimmune skin blistering disease in mice
11. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
Breaking Biology News(10 mins):